Purple Book reference family · 351(a) biologic
autologous cultured chondrocytes on porcine collagen membrane (Maci)
autologous cultured chondrocytes on porcine collagen membrane is an FDA-licensed reference biologic from Vericel Corporation.
351(a) biologicBLA 125603 Vericel Corporation
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
2016
Reference product
Originator biologic
351(a)BLA 125603
Maci autologous cultured chondrocytes on porcine collagen membrane
Vericel Corporation
View full reference-product record- Approved
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Protection horizon
Reference approval
Approval date of the reference autologous cultured chondrocytes on porcine collagen membrane product.
9 yr 9 mo ago
autologous cultured chondrocytes on porcine collagen membrane: frequently asked questions
Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.
Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for autologous cultured chondrocytes on porcine collagen membrane.
Related FDA reference tools
- FDA Orange BookApproved drugs, generics, therapeutic-equivalence codes, patents, and exclusivity.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
